Lenacapavir PrEP ‘special cases’: young people, missed doses and drug interactions
The US opioid crisis has reached older people with HIV
Should event-driven PrEP be an option for women?
Varying dolutegravir distribution across the body may affect the drug’s ability to suppress the HIV reservoir
Too many older people with HIV taking medicines they may not need
Cabotegravir levels lower than trials in real-world study, but no increase in viral rebound
Oral PrEP can work just as well for women as men, modelling studies conclude
Increasing and changing pattern of treatment switches among people with HIV
Bictegravir safe and effective in pregnancy
